Genomically, PTK2B (encoding PYK2) exhibits frequent amplifications and missense mutations in gastrointestinal malignancies (e.g., HCC, PDAC), correlating with metastatic progression and therapy resistance. Here, PTK2B is linked to hepatocellular carcinoma.